EZH2 and neoplasm: showed that in gastric cancer and glioblastoma cell lines EZH2 and DNMT1 together repressed expression of tumor suppressors and that treatment with either the DNMT inhibitor 5-azadeoxycitidine and the methyltransferase inhibitor DZNep reduced tumor growth (31).